Mellinghoff IK - Search Results

1

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.

Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF; INDIGO Trial Investigators. Mellinghoff IK, et al. N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272516 Clinical Trial.

2

Pharmacokinetic Assessment of ¹⁸F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer.

Grkovski M, Goel R, Krebs S, Staton KD, Harding JJ, Mellinghoff IK, Humm JL, Dunphy MPS. Grkovski M, et al. Among authors: mellinghoff ik. J Nucl Med. 2020 Mar;61(3):357-366. doi: 10.2967/jnumed.119.229740. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601700 Free PMC article. Clinical Trial.

3

Cocaine and Buerger disease: is there a pathogenetic association?

Marder VJ, Mellinghoff IK. Marder VJ, et al. Among authors: mellinghoff ik. Arch Intern Med. 2000 Jul 10;160(13):2057-60. doi: 10.1001/archinte.160.13.2057. Arch Intern Med. 2000. PMID: 10888980

4

The emergence of resistance to targeted cancer therapeutics.

Mellinghoff IK, Sawyers CL. Mellinghoff IK, et al. Pharmacogenomics. 2002 Sep;3(5):603-23. doi: 10.1517/14622416.3.5.603. Pharmacogenomics. 2002. PMID: 12223047 Review.

5

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.

Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL. Mellinghoff IK, et al. Cancer Cell. 2004 Nov;6(5):517-27. doi: 10.1016/j.ccr.2004.09.031. Cancer Cell. 2004. PMID: 15542435 Free article.

6

Treatment of Scedosporium apiospermum brain abscesses with posaconazole.

Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ. Mellinghoff IK, et al. Clin Infect Dis. 2002 Jun 15;34(12):1648-50. doi: 10.1086/340522. Epub 2002 May 16. Clin Infect Dis. 2002. PMID: 12032903

7

Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency.

Peng L, Wu TT, Tchieu JH, Feng J, Brown HJ, Feng J, Li X, Qi J, Deng H, Vivanco I, Mellinghoff IK, Jamieson C, Sun R. Peng L, et al. Among authors: mellinghoff ik. J Gen Virol. 2010 Feb;91(Pt 2):463-9. doi: 10.1099/vir.0.015073-0. Epub 2009 Oct 28. J Gen Virol. 2010. PMID: 19864499 Free PMC article.

8

PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors.

Mellinghoff IK, Cloughesy TF, Mischel PS. Mellinghoff IK, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):378-81. doi: 10.1158/1078-0432.CCR-06-1992. Clin Cancer Res. 2007. PMID: 17255257 Review.

9

Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.

Daibata M, Mellinghoff I, Takagi S, Humphreys RE, Sairenji T. Daibata M, et al. J Immunol. 1991 Jul 1;147(1):292-7. J Immunol. 1991. PMID: 1711079

10

Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.

Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Panageas KS, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M, DeAngelis LM, Viale A, Mellinghoff IK, Berger MF. Pentsova EI, et al. Among authors: mellinghoff ik. J Clin Oncol. 2016 Jul 10;34(20):2404-15. doi: 10.1200/JCO.2016.66.6487. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161972 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page